I now have all the content from the PDF. Let me create comprehensive, easy-to-learn notes.
π HAIR DISEASES - EASY STUDY NOTES
(Chapter 24 - Habif's Clinical Dermatology)
π¬ ANATOMY & PHYSIOLOGY
Types of Hair
| Type | Description |
|---|
| Terminal hair | Thick, pigmented - scalp, beard, axilla, pubic area - androgen-dependent |
| Vellus hair | Short, fine, non-pigmented "peach fuzz" - androgen-independent |
| Lanugo hair | Fine hair on fetus |
Hair Follicle Sections (Top to Bottom)
- Infundibulum - surface to sebaceous gland duct
- Isthmus - from sebaceous duct to erector pili muscle insertion
- Inferior segment - exists only during anagen; from muscle to matrix
Hair Shaft Layers (outer β inner)
- Cuticle (outermost - protects cortex)
- Cortex (bulk of shaft - contains pigment melanosomes)
- Medulla (innermost - sometimes absent)
Key Facts
- Humans have ~5 million follicles at birth; NO new follicles form after birth
- Scalp has >100,000 hairs
- Scalp hair grows 0.3-0.4 mm/day (β6 inches/year)
- The bulge (outer root sheath near arrector pili) = stem cell reservoir for follicle regeneration
Hair Growth Cycle
ANAGEN (growing) β CATAGEN (transitional) β TELOGEN (resting) β ANAGEN
2-6 years 2-3 weeks 2-3 months
90-95% <1% 5-10%
| Phase | Key Features |
|---|
| Anagen | Active growth; matrix cells divide rapidly; hair pigmented |
| Catagen | Involution; cell death; club hair forms; hair ascends to erector level |
| Telogen | Resting; club hair (white, solid, dry bulb) held then shed; 25-100 hairs shed/day |
Club hair = dead hair; solid white proximal end; shed during telogen
π EVALUATION OF HAIR LOSS
Systematic Approach (Box 24.1)
History Questions
- Sudden vs gradual
- Systemic disease or fever
- Recent stress (physical/psychological)
- Medications/chemicals
Examination
- Localized vs generalized
- Scarring vs non-scarring
- Inflammatory vs non-inflammatory
- Follicular plugging
Diagnostic Tools
| Test | How | Normal Result |
|---|
| Hair pull test | Grasp 20-40 hairs 3 cm above auricle; slow traction | < 6 club hairs |
| Daily counts | Collect hairs for 14 days in morning combing + wash | < 100/day; < 200 on shampoo days |
| Part width | Coronal parts over vertex - compare part diameter | - |
| Hair pluck (trichogram) | Abruptly extract hairs; examine bulbs | - |
| Trichoscopy | Dermoscope - follicular ostia, shafts, vessels | - |
| Hair growth window | Shave 2 cmΒ² area, occlude 1 week; check regrowth | 2.5 mm/week |
Anagen vs Telogen Hair (Microscopy)
| Anagen Hair | Telogen Hair |
|---|
| Bulb | Elongated, pigmented, broom-shaped | Small, unpigmented, ovoid |
| Sheath | Gelatinous sheath present | No sheath |
π SIMPLIFIED DIAGNOSIS TABLE (97% of cases)
| Disease | Pattern | Pull Test | Treatment |
|---|
| Telogen effluvium | Diffuse | + telogen | Disease-specific |
| Diffuse AA | Irregularly diffuse | + telogen | Topical immunotherapy |
| AGA (men) | Hamilton pattern | Negative | Minoxidil, Finasteride, Surgery |
| AGA (women) | Ludwig pattern | Negative | Minoxidil, Spironolactone |
| Discoid lupus | Patchy, scarring, dyspigmentation | Negative | Intralesional steroids, Hydroxychloroquine |
| Lichen planopilaris | Patchy, scarring | Negative | Intralesional steroids, Hydroxychloroquine |
| Frontal fibrosing | Frontal hairline recession | Negative | Same as LPP |
| Alopecia areata | Patchy, exclamation mark hairs | Maybe + at margins | Intralesional steroids, Minoxidil |
| Tinea capitis | Patchy, scale/pustules | Hair breakage (KOH+) | Oral antifungal |
| Trichotillomania | Patchy with stubble | Usually negative | Fluoxetine, psychotherapy |
| Traction alopecia | Patchy, marginal | Hair breakage | Avoid traction |
| Syphilis | Moth-eaten | + telogen | Penicillin |
π GENERALIZED HAIR LOSS
1. Telogen Effluvium (TE)
Mechanism: Premature termination of anagen β excess follicles enter telogen β massive shedding ~3 months later
Key Features:
- Normal scalp, diffuse loss, NO scarring
- Up to 50% hair affected
- Resting hairs shed ~100 days after trigger
Types:
| Acute TE | Chronic TE (CTE) |
|---|
| Duration | <6 months | >8 months (up to 7 years) |
| Onset | 1-3 months post-event | Abrupt, fluctuating |
| Pattern | Diffuse | Diffuse + bitemporal recession |
| Who | Any | 30-60 yr old women |
| Pull test | >4 hairs | 2-8 hairs |
Common Triggers for TE:
- High fever
- Severe emotional/physical trauma
- Postpartum (1-4 months after delivery - delayed anagen release)
- Drugs (see below)
- Hypothyroidism, iron deficiency
- Crash diets
Drugs Causing Telogen Effluvium:
Acitretin, amphetamines, captopril, carbamazepine, coumadin, lithium, propranolol, valproic acid, heparin, retinoids, anticoagulants, anticonvulsants, antithyroids, beta-blockers, amiodarone, penicillamine
2. Anagen Effluvium
| Feature | Telogen Effluvium | Anagen Effluvium |
|---|
| Onset | 2-4 months after insult | 1-4 weeks after insult |
| Hair loss % | 20-50% | 80-90% |
| Hair type lost | Club hair (white bulb) | Anagen hair (pigmented bulb) |
| Shaft | Normal | Narrowed or fractured |
| Cause | Stress, postpartum, drugs | Chemotherapy, radiation |
Mechanism: Direct insult to matrix cells β hair shaft narrowing β breakage; 90% of hairs affected (all in anagen)
- Scalp hypothermia (DigniCap, Paxman) can minimize chemotherapy-induced loss
3. Loose Anagen Hair Syndrome (LAS)
- Children; female:male = 6:1
- Defective anchorage of hair shaft β easily, painlessly pluckable hair
- Young girl with short blond hair that won't grow long
- Pull test: >10 loose anagen hairs (normal = 1-2)
- Trichogram: β₯70% loose anagen, no telogen
- Most improve with age
π― LOCALIZED HAIR LOSS
Androgenetic Alopecia (AGA) - Men (Male Pattern Baldness)
Key Points:
- Physiologic reaction; polygenic inheritance
- Begins age 12-40; ~50% express before age 50
- Androgen-sensitive follicles on top; androgen-independent on sides/back
Hamilton Pattern Classification:
Type I = Normal (minimal frontotemporal recession)
Type II = Slight frontotemporal recession
Type III = Deep frontotemporal + midfrontal recession
III vertex= Hair loss on vertex
IV-VII = Progressively increasing vertex + frontal baldness
Pathophysiology:
- Testosterone (T) β DHT via 5Ξ±-reductase type II (in hair follicles + prostate)
- DHT binds follicle androgen receptor β miniaturizes follicles
- Terminal hairs β vellus hairs; anagen shortens progressively
- Inflammation around bulge area damages stem cells
Female Pattern Hair Loss (AGA in Women)
Key Features:
- Ludwig pattern: Central scalp thinning; frontal hairline PRESERVED (key difference from men)
- Widening of central hair part
- "Pony tail is thinner"
- Pull test normal; miniaturized hairs of varying diameter
- More common with PCOS and other androgen excess states
Laboratory Workup:
| Parameter | Female AGA | Female AGA + Hirsutism | Male Pattern (Frontotemporal) |
|---|
| DHEA-S | Normal or elevated | Normal/elevated | Elevated |
| Testosterone | Normal | Normal/elevated | Elevated |
| TeBG | Normal | Decreased/normal | Decreased/normal |
π§ HIRSUTISM
Definition: Excessive terminal hair in a MALE pattern in women
Affects: 5-10% of women
Ferriman-Gallwey (mFG) Scoring
- 9 body sites (upper lip, chin, chest, upper/lower back, upper/lower abdomen, arm, thigh)
- Score 0-4 per site
- Score 6-8 = hirsutism in white/black women
- <5% of reproductive-age women score >7
Etiology (Box 24.4)
| Cause | Frequency |
|---|
| PCOS | Most common (>80%) |
| Idiopathic hirsutism | ~10% (normal androgens, normal ovulation) |
| Nonclassic congenital adrenal hyperplasia | ~2% |
| Androgen-secreting tumor | 0.2% (50% malignant) |
| Cushing syndrome | Rare |
| Hyperprolactinemia | Rare |
Virilization = Hirsutism PLUS:
- Clitoral hypertrophy
- Deepening voice
- Temporal balding
- Decreased breast size
- Amenorrhea
- Increased muscle mass
- Acne + increased sebum
β Suggests ovarian or adrenal tumor
Polycystic Ovary Syndrome (PCOS)
Diagnosis: Any 2 of 3:
- Oligomenorrhea/anovulation
- Clinical/biochemical hyperandrogenism (hirsutism, acne, elevated T)
- Polycystic ovaries on ultrasound (>8 follicles/ovary, all <10mm)
(After excluding: congenital adrenal hyperplasia, Cushing, androgen-secreting tumor, acromegaly)
Features:
- 6% of reproductive-age women
- Insulin resistance + hyperinsulinemia
- Elevated LH, T; reduced SHBG
- Obesity in 70%
- 3Γ increased risk of endometrial cancer
- Risk of type 2 DM (up to 40%)
- Impaired glucose tolerance in up to 40%
Alarm Values (Tumor Workup):
- Total T > 6.9 nmol/L (>200 ng/dL)
- DHEA-S > 18.9 nmol/L (>7000 ng/mL)
β Suggests ovarian or adrenal androgen-producing tumor
Hirsutism Treatment Principles
- First-line: Oral contraceptives (suppress LH β β ovarian androgens; β SHBG β β free androgen)
- Add antiandrogen after 6 months if poor response
- At least 6 months of treatment needed for response
- Cosmetic: shaving, waxing, eflornithine cream (Vaniqa), laser/IPL
Antiandrogens: Spironolactone, cyproterone acetate, finasteride, flutamide
- All equally effective
- Teratogenic β always use with contraception
Eflornithine (Vaniqa):
- Irreversible inhibitor of ornithine decarboxylase
- Slows hair growth (not permanent)
- Results in 6-8 weeks; regrows when stopped
Photoepilation (Laser/IPL) Selection:
| Skin/Hair | Device |
|---|
| Light skin/dark hair | Short wavelength laser |
| Dark skin/dark hair | Long wavelength or IPL |
| Light/white hair | IPL + radiofrequency |
π΅ ALOPECIA AREATA (AA)
Definition: Common autoimmune disease; rapid onset total hair loss in sharply defined, round areas
Types:
- AA = Patchy scalp hair loss
- Alopecia totalis = 100% scalp hair loss
- Alopecia universalis = 100% loss of scalp + body hair
- Ophiasis pattern = Band-like loss in parietotemporo-occipital area (poor prognosis)
Prevalence: 0.1-0.2% of US population; 60% present before age 20
Clinical Features
- Smooth, white/normal scalp
- "Exclamation point" hairs - normal upper shaft, narrowed base - at periphery of patch
- Regrowth in 1-3 months; may be white/fine initially
- Eyelashes + beard are second most common sites
Nail Changes (10-66%):
- Pitting (irregular, organized rows, or longitudinal)
- "Sandpaper nails" appearance
Prognosis
- Majority regrow within 1 year without treatment
- 10% develop chronic disease and may never regrow
- Poor prognosis: family history AA, young age, nail dystrophy, atopy, extensive loss, immune diseases
Pathology
- "Swarm of bees" = peribulbar lymphocytic infiltrate
- NO scarring
- Inflammation terminates anagen β catagen
- Bulge SPARED β new hair can regrow after inflammation resolves
Etiology
- Unknown; autoimmune T-lymphocyte mediated
- Associations: thyroid disease (8-11.8%), vitiligo (4Γ increased), atopy (2Γ)
Differential Diagnosis
- Tinea capitis (KOH+, scale)
- Trichotillomania (irregular, broken hairs, not completely bald)
- Secondary syphilis (moth-eaten pattern)
- Telogen effluvium (diffuse, not patchy)
AA Treatment by Age & Severity
Children < 10 years:
- Topical midpotent corticosteroid + 5% minoxidil solution
- Alternative: Anthralin (short contact)
Adults β₯ 10 years, <50% scalp:
- Intralesional corticosteroids (triamcinolone acetonide 5-10 mg/mL)
- Regrowth in 4-8 weeks; 60-67% response rate; repeat every 4-6 weeks
- Β± 5% topical minoxidil twice daily
- Β± Topical corticosteroid
Adults β₯ 10 years, >50% scalp:
- 5% topical minoxidil + topical corticosteroid
- Topical immunotherapy (DPCP) - treatment of choice for >50% scalp in adults
- Anthralin (20-25% response)
- Oral corticosteroids (rarely; high relapse rate)
Topical Immunotherapy (DPCP):
- Diphenylcyclopropenone - first choice for >50% scalp
- Squaric acid dibutyl ester (SADBE) - alternative
- ~60% success rate in experienced hands
- Goal: mild itching, erythema, scaling
π§ TRICHOTILLOMANIA (TTM)
Definition: Chronic impulse control disorder (or OCD-spectrum); repetitive hair-pulling β alopecia
Prevalence: 0.6-13%; average onset age 11-13 years; female:male = 2.5:1
DSM-5 Diagnostic Criteria (Box 24.11)
- Hair loss from recurrent hair-pulling
- Repeated attempts to stop
- Significant distress/impairment
- Not due to dermatologic condition
- Not better explained by another mental disorder
Clinical Features
- Frontoparietal scalp most common (easily reached)
- Irregular, angulated border
- Area is NEVER completely bald (unlike AA)
- Short, broken hairs of varying lengths randomly distributed
- Eyebrows and eyelashes may be involved
Diagnosis
- Ask patient directly about hair manipulation
- No telogen hairs on pull test (nearly 100% anagen)
- Biopsy: normal hairs, absent hairs in follicles, NO leukocyte infiltration; catagen hairs in 74%
- Hair growth window test: cover shaved area for 1 week β normal growth proves hair is growing
Difference from AA:
| TTM | Alopecia Areata |
|---|
| Bald patches | Never completely bald | Completely devoid |
| Hair | Short, broken | Absent; exclamation point hairs |
| Pull test | Negative (all anagen) | Positive at margins |
| Biopsy | Catagen hairs, pigment casts | Swarm of bees infiltrate |
Treatment
- Supportive counseling (physician/parent)
- Habit reversal therapy (superior to pharmacotherapy)
- Clomipramine (more effective than placebo; SSRIs = NOT proven superior to placebo)
- Consider psychiatric referral for extensive cases
β‘οΈ TRACTION ALOPECIA
- Caused by: braids, ponytails, rollers, hot straightening combs
- Hair loss corresponds exactly to the stressed area
- Usually temporary; rarely permanent
- Treatment: Avoid the causative hairstyle
π₯ SCARRING ALOPECIAS
Key principle: Permanent hair loss because follicle is DESTROYED (unlike non-scarring)
Primary vs Secondary Scarring Alopecia
| Primary | Secondary |
|---|
| Target | Follicle is the target | Follicle destroyed by non-follicular process |
| End stage | Smooth skin, no follicular orifices | Same |
Primary - Lymphocytic: DLE, LPP, Frontal fibrosing, Pseudopelade, CCCA
Primary - Neutrophilic: Folliculitis decalvans, Dissecting cellulitis
Primary - Mixed: Acne keloid, Tufted folliculitis, Acne necrotica, Erosive pustular dermatosis
1. Central Centrifugal Cicatricial Alopecia (CCCA)
(formerly: Hot Comb Alopecia, Follicular Degeneration Syndrome)
- Most common cicatricial alopecia in black women
- Starts at vertex, spreads forward/outward
- Early stage: erythema, scaling around follicles; pruritus, scalp tenderness
- Late stage: scarring, fibrosis
- Association with type 2 diabetes mellitus
- Treatment: topical/intralesional corticosteroids, topical minoxidil; doxycycline for inflammatory disease
2. Chronic Cutaneous Lupus Erythematosus (Discoid LE)
- Common cause of scarring alopecia
- More common in women
- Classic lesion: "carpet tack scale" (follicular plugging with scale attached to underside)
- Well-circumscribed, erythematous, scaly plaques β atrophic hypopigmented/hyperpigmented scars
- Immunofluorescence: IgG, IgM deposits at dermoepidermal junction
- Treatment: Topical/intralesional corticosteroids, hydroxychloroquine, oral agents (azathioprine, cyclosporine)
3. Lichen Planopilaris (LPP)
- More common in adult women
- Lesions: centrifugal pattern, vertex-centered
- Spinous, hyperkeratotic follicular papules with perifollicular erythema
- Smooth, atrophic, polygonal-shaped patches; scarring central, active at margins
- Patients: pain, stinging, burning
- Immunofluorescence: cytoid body staining (IgM, IgA) - positive in 50%
- Differential: DLE, pseudopelade, folliculitis decalvans
- Treatment: Superpotent topical steroids, intralesional steroids, short oral steroids; hydroxychloroquine; doxycycline, tetracycline, cyclosporine
4. Frontal Fibrosing Alopecia (FFA)
- Variant of LPP
- Mainly postmenopausal women
- Scarring from frontal hairline extending backward
- Perifollicular erythema + minute perifollicular papules at advancing edge
- Eyebrow loss common
- Biopsy = same as LPP
- Poor prognosis for recovery
5. Pseudopelade (of Brocq)
- Rare, slowly progressive, non-inflammatory scarring alopecia
- "Footprints in the snow" appearance - skin-colored, slightly depressed patches
- Starts on crown; moth-eaten-like patches coalesce
- May be end-stage of other scarring alopecias
- Treatment resistant to topicals; intradermal steroids
6. Folliculitis Decalvans
- Chronic pustular eruption β patchy permanent alopecia
- Crops of pustules surrounding multiple expanding oval areas of alopecia
- Staphylococcus aureus cultured from pustules
- Biopsy: follicular neutrophilic abscesses (early); dermal lymphocytes + scarring (late)
- Treatment: Culture pustules; antibiotics (rifampicin + clindamycin Γ 10 weeks; dapsone); topical mupirocin
7. Dissecting Cellulitis
- Young black men
- Boggy, fluctuant scalp nodules on crown/vertex/occiput
- Interconnected abscesses with sinus tracts β extensive scarring
- Part of "follicular occlusion triad" (dissecting folliculitis + hidradenitis suppurativa + acne conglobata)
- Treatment: Antibiotics; isotretinoin; adalimumab (reported effective)
8. Acne Keloidalis Nuchae
- Young black men (much less common in white men)
- Occipital scalp and posterior neck
- Follicular papules/pustules β fibrosis β firm keloidal papules
- Initially neutrophilic inflammation
- Treatment: Antibiotics (topical and oral); topical/intralesional steroids; surgery in advanced cases
9. Tufted Folliculitis
- End stage of other scarring alopecias (folliculitis decalvans, acne keloidalis, etc.)
- Multiple hairs (2-10+) emerging from single dilated follicular orifice
- Follicular rupture + abscess + fibrosis around follicles
- Treatment: Same as folliculitis decalvans
10. Acne Necrotica
- Severe scalp folliculitis
- Papules/pustules β crusts β depressed scars
- Can also affect face
- Treatment: Minocycline, topical clobetasol
11. Erosive Pustular Dermatosis
- Elderly; actinically damaged scalp
- Often follows trauma or destructive treatment
- Red, pustular, crusted, eroded plaques
- Progressive scarring alopecia
- Biopsy: lymphocytes and plasma cells in dermis
- Treatment: Potent topical steroids, tacrolimus, calcipotriol, acitretin, isotretinoin, topical dapsone gel
π¦ TRICHOMYCOSIS
- Asymptomatic infection of axillary or pubic hair by Corynebacterium
- Hair shaft coated with adherent yellow (occasionally red or black) firm concretions
- Associated with hyperhidrosis
- Treatment: Shave hair; control hyperhidrosis with antiperspirants; Naftifine 1% cream
π₯ QUICK COMPARISON CHART: KEY DISEASES
| Disease | Population | Pattern | Scarring | Key Feature | 1st Line Rx |
|---|
| Telogen effluvium | Any | Diffuse | No | Positive pull test; trigger 3 mo prior | Remove trigger |
| Anagen effluvium | Post-chemo | Diffuse | No | 80-90% loss; 1-4 weeks | Stop offending agent |
| Male AGA | Men | Hamilton | No | DHT-mediated; vertex + frontal | Minoxidil/Finasteride |
| Female AGA | Women | Ludwig | No | Frontal hairline preserved | Minoxidil |
| Alopecia areata | Any, young | Patchy round | No | Exclamation mark hairs; "swarm of bees" | Intralesional steroids |
| Trichotillomania | Children/teens | Irregular patchy | No | Never bald; broken hairs; all anagen | Habit reversal |
| Tinea capitis | Children | Patchy | No | Scale/KOH positive | Oral antifungal |
| DLE | Women | Patchy | Yes | Carpet tack scale; dyspigmentation | Hydroxychloroquine |
| LPP | Adult women | Patchy, vertex | Yes | Perifollicular erythema/papules | Topical/IL steroids |
| FFA | Postmenopausal women | Frontal recession | Yes | Frontal hairline recedes backward | Same as LPP |
| CCCA | Black women | Vertex spreading | Yes | Starts vertex; DM association | IL triamcinolone |
| Folliculitis decalvans | Adults | Patchy | Yes | Peripheral pustules; Staph. aureus | Rifampicin + clindamycin |
| Dissecting cellulitis | Young black men | Crown/vertex | Yes | Boggy abscesses, sinus tracts | Antibiotics/isotretinoin |
| Acne keloidalis | Young black men | Occipital | Yes | Keloidal papules on nape | Antibiotics + steroids |
| Trichomycosis | Any | Axillary/pubic | N/A | Yellow concretions on shaft | Shave + antiperspirant |
π§ͺ ANDROGEN METABOLISM SUMMARY
Testosterone (T)
β [5Ξ±-reductase Type I: sebaceous glands]
β [5Ξ±-reductase Type II: hair follicles, prostate]
DHT (Dihydrotestosterone)
β
Androgen receptor in dermal papilla
β
- Scalp: miniaturizes follicles β AGA
- Beard/chest/pubic: enlarges follicles β terminal hair growth
Finasteride blocks 5Ξ±-reductase Type II
Dutasteride blocks both Type I and Type II
β οΈ HIGH-YIELD POINTS FOR EXAMS
- Telogen effluvium occurs ~3 months after the trigger
- Postpartum hair loss = delayed anagen release (1-4 months post-delivery)
- Exclamation point hairs = pathognomonic of alopecia areata
- "Swarm of bees" peribulbar infiltrate = alopecia areata (no scarring)
- "Carpet tack scale" = Discoid lupus erythematosus
- "Footprints in the snow" = Pseudopelade
- Tufted folliculitis = multiple hairs from single orifice
- Follicular occlusion triad = dissecting folliculitis + hidradenitis suppurativa + acne conglobata
- CCCA is most common cicatricial alopecia in black women
- Dissecting cellulitis + acne keloidalis = young black men
- Anagen hairs = all affected in trichotillomania (no telogen on pull test)
- Hamilton classification = male AGA; Ludwig classification = female AGA
- Ophiasis pattern AA = poor prognosis
- AA prognosis: >1 year disease, alopecia totalis, nail dystrophy, atopy = poor outcome
- PCOS diagnosis requires 2 of 3: oligomenorrhea, hyperandrogenism, polycystic ovaries
- Ferriman-Gallwey score β₯ 6-8 = hirsutism
- 5Ξ±-reductase absent congenitally β AGA does NOT develop (confirms DHT role)
- Finasteride NOT effective in postmenopausal women with AGA
- Habit reversal therapy > pharmacotherapy for trichotillomania
- Trichomycosis = Corynebacterium (NOT fungi, despite the name)
Source: Chapter 24, Habif's Clinical Dermatology